An Overview of International Pharma Regulations - Focus on EU, US, China
Analysis Cloud Talking Tech Sense · Analysis Cloud Ltd
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Further to our introduction to this topic we provide an Overview of International Pharma Regulations. Focusing on those regulations produced by the EU, US and China.
The discussion goes into some details about international pharmaceutical and medical device regulations. EU Annex 1 and EU-GMP guidelines focuses on sterile medicinal product manufacturing within the European Union. Chinese Pharmacopoeia (ChP), United States Pharmacopeia (USP), and European Pharmacopoeia (EuPh) establish quality standards for pharmaceuticals across their respective regions, with increasing harmonisation efforts. Finally, the US FDA Quality Management System Regulation (QMSR) outlines quality standards for medical device manufacturers, aligning with international ISO 13485 standards. These regulations impact numerous industries, emphasising quality, risk management, and compliance to protect public health and facilitate global trade.